{"id":1533,"date":"2026-05-28T20:06:56","date_gmt":"2026-05-29T00:06:56","guid":{"rendered":"https:\/\/www.insilens.com\/?p=1533"},"modified":"2026-05-28T20:08:11","modified_gmt":"2026-05-29T00:08:11","slug":"opti-aml-venetoclax-optimization","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=1533","title":{"rendered":"OPTI-AML Venetoclax Optimization"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1533\" class=\"elementor elementor-1533\">\n\t\t\t\t<div class=\"elementor-element elementor-element-691fb3b5 e-flex e-con-boxed e-con e-parent\" data-id=\"691fb3b5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-506a25c4 elementor-widget elementor-widget-image\" data-id=\"506a25c4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/05\/ChatGPT-Image-May-28-2026-08_05_51-PM-1024x683.png\" class=\"attachment-large size-large wp-image-1534\" alt=\"\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/05\/ChatGPT-Image-May-28-2026-08_05_51-PM-1024x683.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/05\/ChatGPT-Image-May-28-2026-08_05_51-PM-300x200.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/05\/ChatGPT-Image-May-28-2026-08_05_51-PM-768x512.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/05\/ChatGPT-Image-May-28-2026-08_05_51-PM.png 1536w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-714770c6 e-flex e-con-boxed e-con e-parent\" data-id=\"714770c6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3bc3e803 elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"3bc3e803\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Summary<\/h4><p>Blood Cancer United announced more than 50 ASCO and EHA 2026 abstracts, highlighted by an oral EHA presentation from the randomized Phase 2 OPTI-AML substudy evaluating reduced-duration venetoclax dosing with azacitidine in newly diagnosed AML patients aged 60 and older.<\/p><h4>What Happened<\/h4><p>The OPTI-AML substudy compares the standard 28-day venetoclax schedule versus a shortened 14-day schedule combined with azacitidine in elderly AML patients.<\/p><h4>Deep Analysis<\/h4><p>Venetoclax plus azacitidine is already the standard frontline regimen for elderly AML patients, but prolonged cytopenias and treatment interruptions remain major clinical limitations. A shorter schedule could improve tolerability while maintaining efficacy, making this one of the most clinically actionable optimization questions in AML.<\/p><h4>Company \/ Product Background<\/h4><p>Venetoclax is a BCL2 inhibitor used in AML to induce leukemia-cell apoptosis. Azacitidine is a hypomethylating agent widely combined with venetoclax in frontline elderly AML.<\/p><h4>Signal Extraction<\/h4><p>&#8211; AML treatment optimization becoming increasingly important<br \/>&#8211; Shorter venetoclax schedules may improve real-world delivery<br \/>&#8211; Adaptive master-trial platforms gaining influence<\/p><h4>Insilens Take<\/h4><p>&#8211; Opportunity: Practice-changing optimization without new drug approval<br \/>&#8211; Threat: Reduced exposure may lower durability of response<br \/>&#8211; Watch Signal: Comparative remission and survival data at EHA<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Summary Blood Cancer United announced more than 50 ASCO and EHA 2026 abstracts, highlighted by an oral EHA presentation from the randomized Phase 2 OPTI-AML substudy evaluating reduced-duration venetoclax dosing with azacitidine in newly diagnosed AML patients aged 60 and older. What Happened The OPTI-AML substudy compares the standard 28-day venetoclax schedule versus a shortened [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1534,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,3],"tags":[],"class_list":["post-1533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-categories","category-therapeutic-indication"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1533"}],"version-history":[{"count":4,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1533\/revisions"}],"predecessor-version":[{"id":1538,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1533\/revisions\/1538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/1534"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}